Berkshire Hathaway Inc (BRK-B)vsDrugs Made In America Acquisition II Corp. Ordinary Shares (DMII)
BRK-B
Berkshire Hathaway Inc
$514.90
+0.89%
FINANCIAL SERVICES · Cap: $1.09T
DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
$10.16
-0.07%
FINANCIAL SERVICES · Cap: $647.37M
Smart Verdict
WallStSmart Research — data-driven comparison
BRK-B leads profitability with a 22.3% profit margin vs 0.0%. BRK-B trades at a lower P/E of 12.8x. BRK-B earns a higher WallStSmart Score of 74/100 (B).
BRK-B
Strong Buy74
out of 100
Grade: B
DMII
Avoid32
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Reasonable price relative to book value
Strong operational efficiency at 32.6%
Earnings expanding 107.8% YoY
Keeps 22 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Comparative Analysis Report
WallStSmart ResearchBull Case : BRK-B
The strongest argument for BRK-B centers on Market Cap, Price/Book, Operating Margin. Profitability is solid with margins at 22.3% and operating margin at 32.6%.
Bull Case : DMII
The strongest argument for DMII centers on Debt/Equity.
Bear Case : BRK-B
The primary concerns for BRK-B are Piotroski F-Score, PEG Ratio.
Bear Case : DMII
The primary concerns for DMII are P/E Ratio, Revenue Growth, EPS Growth.
Key Dynamics to Monitor
BRK-B profiles as a mature stock while DMII is a value play — different risk/reward profiles.
BRK-B is growing revenue faster at 10.0% — sustainability is the question.
BRK-B generates stronger free cash flow (5.6B), providing more financial flexibility.
Monitor INSURANCE - DIVERSIFIED industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BRK-B scores higher overall (74/100 vs 32/100), backed by strong 22.3% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Berkshire Hathaway Inc
FINANCIAL SERVICES · INSURANCE - DIVERSIFIED · USA
Berkshire Hathaway Inc. is an American multinational conglomerate holding company headquartered in Omaha, Nebraska, United States. The company wholly owns GEICO, Duracell, Dairy Queen, BNSF, Lubrizol, Fruit of the Loom, Helzberg Diamonds, Long & Foster, FlightSafety International, Pampered Chef, Forest River, and NetJets, and also owns 38.6% of Pilot Flying J; and significant minority holdings in public companies Kraft Heinz Company (26.7%), American Express (18.8%), The Coca-Cola Company (9.32%), Bank of America (11.9%), and Apple (6.3%).
Visit Website →Drugs Made In America Acquisition II Corp. Ordinary Shares
FINANCIAL SERVICES · SHELL COMPANIES · USA
Drugs Made In America Acquisition II Corp. (DMII) is a special purpose acquisition company (SPAC) focused on identifying and merging with innovative players in the pharmaceuticals and biotechnology sectors, prioritizing advancements in domestic drug manufacturing. Leveraging a seasoned management team with considerable industry expertise, DMII aims to execute strategic transactions that respond to market dynamics and foster sustainable practices. The company's mission encompasses enhancing supply chain resilience and promoting U.S. healthcare self-sufficiency, ultimately driving long-term value creation for shareholders and contributing to the growth of the American pharmaceutical landscape.
Compare with Other INSURANCE - DIVERSIFIED Stocks
Want to dig deeper into these stocks?